from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2035/-

LFCtreatmentdescriptionclass of inhibitor

1.547

Amikacinug/mL Amikacintranslation

0.400

Cap5-10ug/mL Capreomycintranslation

1.180

Rox10-50 ug/mL Roxithromycintranslation

-0.167

SM2-5 ug/mL Streptomycintranslation

1.189

Tet5-10 ug/mL Tetracyclinetranslation

-0.075

Rif0.2-5ug/mL Rifampicintranscription

1.072

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.392

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.917

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.114

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.183

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.481

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.578

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.297

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.913

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.552

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.686

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.425

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.146

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.209

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.069

KCN5-20 ug/mL Potassium cyaniderespiration

-0.509

NaN30.2-2 mM Sodium aziderespiration

-0.224

Nigericin50 uM Nigericinrespiration

0.751

TRC10-150 ug/mL Triclosanrespiration

1.095

TRZ10-25 ug/mL Thioridazinerespiration

2.467

Valinomycin0.5-10 uM Valinomycinrespiration

-0.060

ZnSO42 mM ZnSO4respiration

0.021

menadione6-10 ug/mL Menadionerespiration

-0.622

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.648

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.295

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.418

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.835

NRP_1Non-replicating persistence stage 1dosRassociated

-0.714

Amp0.2mg/mL AmpicillincellWall

-0.565

Cephalexin20-100 ug/mL CephalexincellWall

-0.530

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.226

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.824

EMB10-20 ug/mL EthambutolcellWall

-0.783

Eta12-40 ug/mL EthionamidecellWall

-1.343

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.234

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.166

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.730

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.387

BZA0.12 mg/mL BenzamidearomaticAmides

0.350

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.159

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.284

H2O24 mM hydrogen peroxideDNAdamaging

-0.347

Levo10 ug/mL LevofloxacinDNAdamaging

-0.296

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.020

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.412

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.589

UVUV-irradiationDNAdamaging

0.727

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.603

Antimycin12.5-50 ug/mL Antimycin A?

-0.538

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.305

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.606

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.295

PA8240.2-2 ug/mL PA-824?

-0.081

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.677

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.033

Verapamil50 uM Verapamil?

-0.446

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.991

methoxatin10-20 ug/mL Methoxatin?